Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
Status:
Not yet recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The multicenter collaborative clinical study conducted a systematic clinical observation in
the treatment of bone marrow failure diseases via UCB&UC-MSCs , in order to observe its
clinical efficacy and safety.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Shandong Qilu Stem Cells Engineering Co., Ltd.
Collaborators:
Air Force Hospital of Western War Zone Binzhou People's Hospital Dezhou People's Hospital Gansu Provincial Hospital of Traditional Chinese Medicine (TCM) Gansu Wuwei Tumour Hospital Jiangxi Province Children's Hospital Kaifeng Central Hospital Lanling People's Hospital Linyi Central Hospital Linyi People's Hospital Qilu Children's Hospital of Shandong University Rizhao People's Hospital Shandong Jining No.1 People's Hospital Shandong Third Provincial Hospital Shengli Oilfield Central Hospital Tai'an Central Hospital The Affiliated Hospital of Binzhou Medical College The affiliated hospital of Jining medical college The First People' s Hospital of Yunnan Province The First People's Hospital of Jingzhou The Second Affiliated Hospital of Harbin Medical University The Second Affiliated Hospital of Shandong First Medical University The Second Affiliated Hospital of Shandong University of traditional Chinese Medicine Weihai Central Hospital Weihai Municipal Hospital Wuwei People's Hospital Yuncheng Institute of Hematology Zhengzhou Central Hospital Zibo municipal hospital Zigong No.1 Peoples Hospital